Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sakib Burza

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Plos Neglected Tropical Diseases|January 7, 2014
Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, IndiaSakib Burza, Prabhat Kumar Sinha, Raman Mahajan, et al.
Expert Opinion on Emerging Drugs|November 22, 2012
Liposomal amphotericin B as a treatment for human leishmaniasisManica Balasegaram, Koert Ritmeijer, Maria Angeles Lima, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 20, 2018
Safety and Effectiveness of Short-Course AmBisome in the Treatment of Post-Kala-Azar Dermal Leishmaniasis: A Prospective Cohort Study in BangladeshMargriet den Boer, Asish Kumar Das, Fatima Akhter, et al.
Plos Neglected Tropical Diseases|January 7, 2014
Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) in Bihar, IndiaSakib Burza, Prabhat K Sinha, Raman Mahajan, et al.
BMC Nutrition|March 11, 2020
Malnutrition in Chakradharpur, Jharkhand: an anthropological study of perceptions and care practices from IndiaIpsha Chaand, Minashree Horo, Mohit Nair, et al.
Plos Neglected Tropical Diseases|August 30, 2022
Prevalence and determinants of asymptomatic Leishmania infection in HIV-infected individuals living within visceral leishmaniasis endemic areas of Bihar, IndiaRaman Mahajan, Sophie I Owen, Shiril Kumar, et al.
Plos Neglected Tropical Diseases|January 7, 2014
Five-year field results and long-term effectiveness of 20 mg/kg liposomal amphotericin B (Ambisome) for visceral leishmaniasis in Bihar, IndiaSakib Burza, Prabhat K Sinha, Raman Mahajan, et al.
BMJ Open|May 1, 2021
Evaluation of qPCR on blood and skin microbiopsies, peripheral blood buffy coat smear, and urine antigen ELISA for diagnosis and test of cure for visceral leishmaniasis in HIV-coinfected patients in India: a prospective cohort studySophie I Owen, Sakib Burza, Shiril Kumar, et al.
Emerging Infectious Diseases|February 26, 2024
Source Tracing of Leishmania donovani in Emerging Foci of Visceral Leishmaniasis, Western NepalPieter Monsieurs, Kristien Cloots, Surendra Uranw, et al.
Plos One|January 25, 2024
Correction: Doing our best and doing no harm: A focused ethnography of staff moral experiences of providing palliative care at a Médecins Sans Frontières pediatric hospital in Cox's Bazar, BangladeshRachel Yantzi, Md Hadiuzzaman, Pradip Kumar Sen Gupta, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Plos Neglected Tropical Diseases|January 7, 2014
Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, IndiaSakib Burza, Prabhat Kumar Sinha, Raman Mahajan, et al.
Expert Opinion on Emerging Drugs|November 22, 2012
Liposomal amphotericin B as a treatment for human leishmaniasisManica Balasegaram, Koert Ritmeijer, Maria Angeles Lima, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 20, 2018
Safety and Effectiveness of Short-Course AmBisome in the Treatment of Post-Kala-Azar Dermal Leishmaniasis: A Prospective Cohort Study in BangladeshMargriet den Boer, Asish Kumar Das, Fatima Akhter, et al.
Plos Neglected Tropical Diseases|January 7, 2014
Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) in Bihar, IndiaSakib Burza, Prabhat K Sinha, Raman Mahajan, et al.
BMC Nutrition|March 11, 2020
Malnutrition in Chakradharpur, Jharkhand: an anthropological study of perceptions and care practices from IndiaIpsha Chaand, Minashree Horo, Mohit Nair, et al.
Plos Neglected Tropical Diseases|August 30, 2022
Prevalence and determinants of asymptomatic Leishmania infection in HIV-infected individuals living within visceral leishmaniasis endemic areas of Bihar, IndiaRaman Mahajan, Sophie I Owen, Shiril Kumar, et al.
Plos Neglected Tropical Diseases|January 7, 2014
Five-year field results and long-term effectiveness of 20 mg/kg liposomal amphotericin B (Ambisome) for visceral leishmaniasis in Bihar, IndiaSakib Burza, Prabhat K Sinha, Raman Mahajan, et al.
BMJ Open|May 1, 2021
Evaluation of qPCR on blood and skin microbiopsies, peripheral blood buffy coat smear, and urine antigen ELISA for diagnosis and test of cure for visceral leishmaniasis in HIV-coinfected patients in India: a prospective cohort studySophie I Owen, Sakib Burza, Shiril Kumar, et al.
Emerging Infectious Diseases|February 26, 2024
Source Tracing of Leishmania donovani in Emerging Foci of Visceral Leishmaniasis, Western NepalPieter Monsieurs, Kristien Cloots, Surendra Uranw, et al.
Plos One|January 25, 2024
Correction: Doing our best and doing no harm: A focused ethnography of staff moral experiences of providing palliative care at a Médecins Sans Frontières pediatric hospital in Cox's Bazar, BangladeshRachel Yantzi, Md Hadiuzzaman, Pradip Kumar Sen Gupta, et al.
Pageof 7